Skip to main content

Advertisement

Log in

Lysionotin attenuates Staphylococcus aureus pathogenicity by inhibiting α-toxin expression

  • Applied microbial and cell physiology
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

α-Toxin, one of the best known pore-forming proteins produced by Staphylococcus aureus (S. aureus), is a critical virulence factor in multiple infections. The necessity of α-toxin for S. aureus pathogenicity suggests that this toxin is an important target for the development of a potential treatment strategy. In this study, we showed that lysionotin, a natural compound, can inhibit the hemolytic activity of culture supernatants by S. aureus by reducing α-toxin expression. Using real-time PCR analysis, we showed that transcription of hla (the gene encoding α-toxin) and agr (the locus regulating hla) was significantly inhibited by lysionotin. Lactate dehydrogenase and live/dead assays indicated that lysionotin effectively protected human alveolar epithelial cells against S. aureus, and in vivo studies also demonstrated that lysionotin can protect mice from pneumonia caused by S. aureus. These findings suggest that lysionotin is an efficient inhibitor of α-toxin expression and shows significant protection against S. aureus in vitro and in vivo. This study supports a potential strategy for the treatment of S. aureus infection by inhibiting the expression of virulence factors and indicates that lysionotin may be a potential treatment for S. aureus pneumonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Bubeck Wardenburg J, Patel RJ, Schneewind O (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75(2):1040–1044. doi:10.1128/IAI.01313-06

    Article  PubMed  Google Scholar 

  • Bubeck Wardenburg J, Schneewind O (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205(2):287–294. doi:10.1084/jem.20072208

    Article  PubMed  Google Scholar 

  • Chen JW, Zhu ZQ, Hu TX, Zhu DY (2002) Structure-activity relationship of natural flavonoids in hydroxyl radical-scavenging effects. Acta Pharmacol Sin 23(7):667–672

    CAS  PubMed  Google Scholar 

  • Escaich S (2008) Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin Chem Biol 12(4):400–408. doi:10.1016/j.cbpa.2008.06.022

    Article  CAS  PubMed  Google Scholar 

  • Gordon RJ, Lowy FD (2008) Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46(Suppl 5):S350–S359. doi:10.1086/533591

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gouaux E (1998) alpha-Hemolysin from Staphylococcus aureus: an archetype of beta-barrel, channel-forming toxins. J Struct Biol 121(2):110–122. doi:10.1006/jsbi.1998.3959

    Article  CAS  PubMed  Google Scholar 

  • McElroy MC, Harty HR, Hosford GE, Boylan GM, Pittet JF, Foster TJ (1999) Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 67(10):5541–5544

    CAS  PubMed  PubMed Central  Google Scholar 

  • Micek ST, Dunne M, Kollef MH (2005) Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128(4):2732–2738. doi:10.1378/chest.128.4.2732

    Article  CAS  PubMed  Google Scholar 

  • Nguyen VT, Kamio Y (2004) Cooperative assembly of beta-barrel pore-forming toxins. J Biochem 136(5):563–567. doi:10.1093/jb/mvh160

    Article  CAS  PubMed  Google Scholar 

  • Ohlsen K, Ziebuhr W, Koller KP, Hell W, Wichelhaus TA, Hacker J (1998) Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 42(11):2817

    CAS  PubMed  PubMed Central  Google Scholar 

  • Padmanabhan RA, Fraser TG (2005) The emergence of methicillin-resistant Staphylococcus aureus in the community. Cleve Clin J Med 72(3):235–241

    Article  PubMed  Google Scholar 

  • Parker D, Prince A (2012) Immunopathogenesis of Staphylococcus aureus pulmonary infection. Semin Immunopathol 34(2):281–297. doi:10.1007/s00281-011-0291-7

    Article  CAS  PubMed  Google Scholar 

  • Qiu J, Niu X, Dong J, Wang D, Wang J, Li H, Luo M, Li S, Feng H, Deng X (2012a) Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of alpha-hemolysin. J Infect Dis 206(2):292–301. doi:10.1093/infdis/jis336

    Article  CAS  PubMed  Google Scholar 

  • Qiu J, Niu X, Wang J, Xing Y, Leng B, Dong J, Li H, Luo M, Zhang Y, Dai X, Luo Y, Deng X (2012b) Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia. PLoS One 7(3):e33032. doi:10.1371/journal.pone.0033032

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9(2):117–128. doi:10.1038/nrd3013

    Article  CAS  PubMed  Google Scholar 

  • Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP (1986) Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet 202(1):58–61

    Article  CAS  PubMed  Google Scholar 

  • Suksamrarn A, Poomsing P, Aroonrerk N, Punjanon T, Suksamrarn S, Kongkun S (2003) Antimycobacterial and antioxidant flavones from Limnophila geoffrayi. Arch Pharm Res 26(10):816–820

    Article  CAS  PubMed  Google Scholar 

  • Tan SY, Tatsumura Y (2015) Alexander Fleming (1881–1955): discoverer of penicillin. Singap Med J 56(7):366–367

    Article  Google Scholar 

  • Uhlemann AC, Otto M, Lowy FD, DeLeo FR (2014) Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect Genet Evol 21:563–574. doi:10.1016/j.meegid.2013.04.030

    Article  PubMed  Google Scholar 

  • Vardakas KZ, Matthaiou DK, Falagas ME (2009) Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J 34(5):1148–1158. doi:10.1183/09031936.00041009

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Qiu J, Dong J, Li H, Luo M, Dai X, Zhang Y, Leng B, Niu X, Zhao S, Deng X (2011) Chrysin protects mice from Staphylococcus aureus pneumonia. J Appl Microbiol 111(6):1551–1558. doi:10.1111/j.1365-2672.2011.05170.x

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Zhou X, Li W, Deng X, Deng Y, Niu X (2016) Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of alpha-hemolysin. Sci Rep 6:28254. doi:10.1038/srep28254

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124(5):1789–1797

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by the National Basic Research Program of China (No. 2013CB127205) and the National Natural Science Foundation of China (grant 31602109).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xuming Deng or Jianfeng Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teng, Z., Shi, D., Liu, H. et al. Lysionotin attenuates Staphylococcus aureus pathogenicity by inhibiting α-toxin expression. Appl Microbiol Biotechnol 101, 6697–6703 (2017). https://doi.org/10.1007/s00253-017-8417-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-017-8417-z

Keywords

Navigation